Abstract:Ovarian cancer (OC) is among the most prevalent malignant tumors in the field of gynecology, and it is the primary cause of death among cancers affecting the female reproductive system. The prognosis for OC is unfavorable, with a 5-year survival rate of approximately 47%. [ 1 ] In recent years, the potential connection between the microbiota and the development of cancer has emerged as a topic of increasing interest and debate. Among the different regions of the body, the human gut microbiota (GM) is particularly noteworthy as a vital constituent of the human microbiome, displaying the greatest bacterial richness and diversity. [ 2 ] Dysbiosis in the GM seems to contribute to the development of cancer by disrupting the physiological balance of intestinal epithelial cells. A representative microbiota has been identified in women with OC: a unique set of viruses, bacteria, fungi, and parasites have been identified in a pan-pathogen array. [ 3 ] Substantial efforts have been devoted to elucidating the pathophysiological mechanisms underlying carcinogenesis driven by microbial factors. Well-established factors, such as the tumor-promoting microenvironment, epithelial barrier dysfunction, altered metabolic processes, and immune dysregulation, have been linked to specific bacteria within dysbiotic microbial communities. [ 4 ] Research has demonstrated that an imbalance in the GM can impact the levels of human metabolites, thereby influencing tumor occurrence and development. [ 5–10 ] Given that patients diagnosed with OC frequently experience gastrointestinal symptoms like abdominal pain, bloating, indigestion, constipation, and early satiety, exploring the potential link between alterations in the GM and OC carcinogenesis is indeed intriguing. Nevertheless, the research on the complex interactions between GM, associated metabolites, and OC has a rather limited scope. Therefore, there is a need for comprehensive exploration to understand the complex mechanisms by which changes in GM and related metabolites impact OC development and treatment pathways, as well as to identify potential metabolites that can be utilized for early diagnosis and clinical therapeutic targets.

Effect Of Polymorphism In One-Carbon Metabolism Pathway On Survival Of Gastric Cancer Patients In A Large And Comprehensive Study.

Single-cell Sequencing Analysis Reveals Gastric Cancer Microenvironment Cells Respond Vastly Different to Oxidative Stress.

Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study.

Prognostic Effects of the Gastric Mucosal Microbiota in Gastric Cancer

Relationship between metabolic enzyme polymorphism and colorectal cancer.

The Effects of Genomic Polymorphisms in One-Carbon Metabolism Pathways on Survival of Gastric Cancer Patients Received Fluorouracil-Based Adjuvant Therapy

&Lt;em>ercc1</em> Rs3212986 A/C Polymorphism is Not Associated with Chemotherapy Treatment Outcomes in Gastric Cancer Patients: Evidence from 11 Publications in Chinese Populations

The Combination of Exon Sequencing and Metabolomics to Establish a Molecular Typing System for Gastric Cancer

Effects of Igf2bp2, Kcnq1 and Gckr Polymorphisms on Clinical Outcome in Metastatic Gastric Cancer Treated with Eof Regimen

Association between gut microbiota, plasma metabolites, and ovarian cancer: A Mendelian randomization study

Influence of Hypoxia-Related Genetic Polymorphisms on the Prognosis of Patients with Metastatic Gastric Cancer Treated with EOF

Relationship Between Polymorhisms of Related Genes in the Folic Acid Metabolic Pathway and the Survival of Gastric Cancer Patients Treated with Capecitabine Combined with Paclitaxel

Genetic Polymorphisms in Selected Phase II Drug-Metabolizing Enzymes in Relation to Breast Cancer Survival

Associations of one-carbon metabolism-related gene polymorphisms with breast cancer risk are modulated by diet, being higher when adherence to the Mediterranean dietary pattern is low

A Combined Effect of Expression Levels of Obesity-Related Genes and Clinical Factors on Cancer Survival Rate

Pan-cancer Characterization of Metabolism-Related Biomarkers Identifies Potential Therapeutic Targets

Characterization of Glycometabolism and Tumor Immune Microenvironment for Predicting Clinical Outcomes in Gastric Cancer.

Progress in the Study of Gene Polymorphism and Gastric Carcinoma

The Effect of CYP1A1 and CYP1A2 Polymorphisms on Gastric Cancer Risk among Different Ethnicities: a Systematic Review and Meta-Analysis.

Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay

Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer